
AI diagnostic tools face hurdles in adrenal tumor testing
Machine learning shows promise in refining blood tests for rare adrenal tumors, but researchers warn that algorithms often rely on clinical shortcuts rather than pure biochemical data. A study presented at the ADLM 2026 meeting reveals that models can inadvertently mirror physician ordering habits, potentially skewing diagnostic accuracy.

























